Filters

Arabidopsis thaliana Probable monodehydroascorbate reductase, cytoplasmic isoform 2 (At3g27820)

Arabidopsis thaliana Probable monodehydroascorbate reductase, cytoplasmic isoform 2 (At3g27820) size: 100ug 2354

Price 2354
Size 100ug
Long name cytoplasmic isoform 2 (At3g27820), Recombinant Arabidopsis thaliana Probable monodehydroascorbate reductase
Alternative names Probable monodehydroascorbate reductase, cytoplasmic isoform 2, monodehydroascorbate reductase (NADH), monodehydroascorbate reductase (NADH)
Gene nameAt3g27820
Other gene names ATMDAR4, At3g27820, MDAR 2, MDAR4, MONODEHYDROASCORBATE REDUCTASE 4, monodehydroascorbate reductase 4, MDAR4
General description All of our recombinant proteins are manufactured in strictly controlled facilities and by using a well established technology which guarantees full batch-to-bact consistency and experiment reproducibility, The protein can be with or without a His-Tag or other tag in accordance to customer's request, cytoplasmic isoform 2 (At3g27820) is a recombinant protein expressed in Baculovirus , Probable monodehydroascorbate reductase
Product categoryRecombinant Proteins
Expression systemBaculovirus
Available also expressed in: Baculovirus , Mammalian Cell, Yeast , E Coli
PurityGreater than 90% (determined by SDS-PAGE)
FormLyophilized protein
Storage Avoid cycles of freezing and thawing as they might denaturate the polypeptide chains, For extended periods of time it is recommended to keep the protein frozen at -40 or -80 degrees Celsius, This protein can be stored at -20 degrees Celsius
Applications IFA, RIA, Western Blot, etc, This protein can be used as a positive control for applications such as ELISA
Gene target cytoplasmic isoform 2 (At3g27820), Arabidopsis thaliana Probable monodehydroascorbate reductase
Short name cytoplasmic isoform 2 (At3g27820), Arabidopsis thaliana Probable monodehydroascorbate reductase
Alternative name cytoplasmic isoform 2 (At3g27820), Arabidopsis thaliana Probable monodehydroascorbate reductase

Similar products

Subscribe to our Newsletter